California BiotechnologyInc said it expects to report a loss of 1,300,000 dlrs to1,600,000 dlrs for the first quarter due to increasedinvestment in research and manufacturing and a scaleup ofproduction.    The company said research spending is running 50 to 60 pctabove a year ago as it tries to commercialize its products asquickly as possible, and increased expenditures are expected tocontinue for several more quarters.  It said operating resultswill fluctuate quarter to quarter, depending on the timing ofsignificant payments from commercial partners.    In the first three months of 1986, the company lost 150,000dlrs.  The company changed its fiscal year in 1986 to acalendar year from a year ending November 30.  For the firstquarter of last year, ended February 28, California Biotechearned 114,000 dlrs. Reuter&#3;